SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016848
Filing Date
2022-11-08
Accepted
2022-11-08 16:01:58
Documents
88
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20220930x10q.htm   iXBRL 10-Q 2782827
2 EX-3.1 kala-20220930xex3d1.htm EX-3.1 139140
3 EX-3.2 kala-20220930xex3d2.htm EX-3.2 189762
4 EX-31.1 kala-20220930xex31d1.htm EX-31.1 15206
5 EX-31.2 kala-20220930xex31d2.htm EX-31.2 15180
6 EX-32.1 kala-20220930xex32d1.htm EX-32.1 6735
7 EX-32.2 kala-20220930xex32d2.htm EX-32.2 6847
  Complete submission text file 0001558370-22-016848.txt   10427812

Data Files

Seq Description Document Type Size
8 EX-101.SCH kala-20220930.xsd EX-101.SCH 68767
9 EX-101.CAL kala-20220930_cal.xml EX-101.CAL 64055
10 EX-101.DEF kala-20220930_def.xml EX-101.DEF 326068
11 EX-101.LAB kala-20220930_lab.xml EX-101.LAB 571425
12 EX-101.PRE kala-20220930_pre.xml EX-101.PRE 444824
82 EXTRACTED XBRL INSTANCE DOCUMENT kala-20220930x10q_htm.xml XML 1776035
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 221368750
SIC: 2834 Pharmaceutical Preparations